MKI67 and neoplasm: Various monoclonal antibodies were used to evaluate the tumor cells immunohistochemically, including antisynaptophysin, chromogranin A, estrogen receptor (ER), progesterone receptor (PgR), human epidermal growth factor receptor 2 (HER-2), bcl-2, p53, and Ki-67 antibodies.